Botanical species · safety record

Lupinus reflexus

The EFSA Compendium of Botanicals holds 6 constituent measurements and 2 adverse-effect records for Lupinus reflexus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lupinus reflexus Rose

6Constituent measurements
2Safety records
3Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • (-)-sparteine1
  • 13-hydroxylupanine1
  • 3-hydroxylupanine1
  • Cyanogenic glycosides1
  • Isoflavones1
  • Lupanine1

Plant parts

  • Seed7
  • Live plants1

Preparations

  • Solvent extraction6

Effect types

  • Digestive2

Target tissues

  • Digestive: pancreas2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
(-)-sparteineSeedSolvent extraction26.63 Milligram/gramUnspecifiedResolve DOI
13-hydroxylupanineSeedSolvent extraction0.08 Milligram/gramUnspecifiedResolve DOI
3-hydroxylupanineSeedSolvent extraction0.16 Milligram/gramUnspecifiedResolve DOI
Cyanogenic glycosidesSeed< 0.01 Milligram/100 gramUnspecifiedResolve DOI
IsoflavonesLive plantsSolvent extractionHPLC-UVResolve DOI
LupanineSeedSolvent extraction2.91 Milligram/gramUnspecifiedResolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestive: pancreasSeedIn vitroResolve DOI
DigestiveDigestive: pancreasSeedSolvent extractionIn vitroResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Ruiz, MA., Sotelo, A. Chemical composition, nutritive value, and toxicology evaluation of Mexican wild lupins . Journal of agricultural and food chemistry, 2001, vol. 49, no. 11, p. 5336-5339. DOI
  2. Ruiz-Lopez, M. A., Garcia-Lopez, P. M., Castaneda-Vazquez, H., Zamora, N. J. F., Garzon-De la Mora, P., Banuelos Pineda, J., Burbano, C., Pedrosa, M. M., Cuadrado, C., Muzquiz, M. Chemical composition and antinutrient content of three Lupinus species from Jalisco, Mexico . Journal of food composition and analysis, 2000, vol. 13, no. 3, p. 193-199. DOI
  3. Stobiecki, Maciej., Staszkow, Anna., Piasecka, Anna., Garcia-Lopez, Pedro M., Zamora-Natera, Francisco., Kachlicki, Piotr. LC-MSMS Profiling of Flavonoid Conjugates in Wild Mexican Lupine, Lupinus reflexus . Journal of natural products, 2010, vol. 73, no. 7, p. 1254-1260. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue